Applicant, as named in the Orange Book

Padagis Us

Next listed expiry: Clindesse on 2 Dec 2026. 1 products with live protection, 4 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Clindesse NDA 050793 clindamycin phosphate	clindamycin phosphate	2 Dec 2026 patent	patent

Recent events

Clindesse · Enters 12-month window basis: patentListed date 2 Dec 2026Detected 24 Oct 2026

Products without listed protection (4)

Drug	Ingredient	Earliest generic entry	Basis
Desonide NDA 017426 desonide	desonide	open now no listed protection	no listed protection
Entocort Ec NDA 021324 budesonide	budesonide	open now no listed protection	no listed protection
Evamist NDA 022014 estradiol	estradiol	open now no listed protection	no listed protection
Midamor NDA 018200 amiloride hydrochloride	amiloride hydrochloride	open now no listed protection	no listed protection